CalciMedica, Inc. — Director's Dealing 2020

Sep 24, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GRAYBUG VISION, INC. (GRAY)
CIK: 0001534133
Period of Report: 2020-09-24

Reporting Person: Flynn James E (10% Owner, Possible Member of 10% Group)
Reporting Person: Deerfield Mgmt HIF, L.P. (10% Owner, Possible Member of 10% Group)
Reporting Person: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (10% Owner, Possible Member of 10% Group)
Reporting Person: Deerfield Healthcare Innovations Fund, L.P. (10% Owner, Possible Member of 10% Group)
Reporting Person: DEERFIELD PARTNERS, L.P. (10% Owner, Possible Member of 10% Group)
Reporting Person: Deerfield Mgmt III, L.P. (10% Owner, Possible Member of 10% Group)
Reporting Person: Deerfield Private Design Fund III, L.P. (10% Owner, Possible Member of 10% Group)
Reporting Person: Deerfield Mgmt L.P. (10% Owner, Possible Member of 10% Group)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Preferred Stock	$		Common Stock (1422406)		Indirect
Series B Preferred Stock	$		Common Stock (1422406)		Indirect
Series C Preferred Stock	$		Common Stock (291467)		Indirect
Series C Preferred Stock	$		Common Stock (291467)		Indirect
Series C Preferred Stock	$		Common Stock (291467)		Indirect

Footnotes

F1: Each share of Series B Preferred Stock is convertible into approximately 0.11103955 shares of the Issuer's common stock (on an adjusted basis after giving effect to the 1-for-9.0058 reverse split of the Issuer's common stock effected by the Issuer on September 18, 2020) and will automatically convert into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering of common stock.

F2: Each share of Series C Preferred Stock is convertible into approximately 0.11103955 shares of the Issuer's common stock (on an adjusted basis after giving effect to the 1-for-9.0058 reverse split of the Issuer's common stock effected by the Issuer on September 18, 2020) and will automatically convert into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering of common stock.

F3: This Form 3 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield Innovations"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (collectively with Fund III and Deerfield Innovations, the "Funds"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F4: In accordance with Instruction 5 (b)(iv) to Form 3, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.